• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Limoneira Announces Appointment of Elizabeth Mora to Board of Directors

    10/27/21 8:30:00 AM ET
    $INGN
    $LMNR
    $MKSI
    Industrial Specialties
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $INGN alert in real time by email

    Seasoned Corporate Environmental Social and Governance ("ESG") Professional

    Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced the appointment of Elizabeth (Beth) Mora to the Company's Board of Directors. Following the appointment of Ms. Mora, the Board will be comprised of 11 directors, nine of whom are independent.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005021/en/

    Elizabeth Mora (Photo: Business Wire)

    Elizabeth Mora (Photo: Business Wire)

    Limoneira Chairman of the Board, Gordon Kimball, stated, "We are thrilled to welcome Ms. Mora to our board and believe her 30+ years of expansive industry experience, financial acumen and ESG expertise, will be a valuable addition to Limoneira. Ms. Mora is known as a strategic thought leader and a champion for diversity and inclusion and her guidance and leadership will be instrumental as we continue to evolve as a company."

    Ms. Mora is a seasoned board director, financial expert, and business operations executive, who built her career in the accounting, education and technology and research industries. Ms. Mora's more than 30-year career began at PricewaterhouseCoopers and her most recent role was as Chief Administrative Officer, Vice President for Finance, Administration and Treasurer at the Charles Stark Draper Laboratory, Inc. (Draper), a position she held from 2008 to 2020. Previously, Ms. Mora served in a variety of executive management roles at Harvard University from 1997 to 2008, including as Chief Financial Officer and Vice President for Finance and Associate Vice President, Research Administration. Ms. Mora currently serves as a board member for Inogen Inc. (NASDAQ:INGN), a medical technology company; MKS Instruments (NASDAQ:MKSI), a global semi-conductor equipment, laser, and laser packaging company; and Belay Associates, Everest Consolidator LLC, a private equity firm. Ms. Mora is a Certified Public Accountant and holds a Bachelor of Arts from the University of California, Berkeley, and a Master of Business Administration from Simmons College.

    During Ms. Mora's tenure as Chief Administrative Officer at Draper, she was instrumental in expanding the percentage of women and underrepresented minority employees from 10% to 25% of the employee base in six years. In addition, she ensured Draper was a strong supporter of the "Community Compact for a Sustainable Future" signed by Cambridge, Massachusetts, Harvard University and the Massachusetts Institute of Technology. Cambridge was the first city in the US to adopt sustainability guidelines for non-profits and businesses located in the city. Ms. Mora and her wife reside in the Boston area.

    "I am excited to be joining Limoneira's Board of Directors and working with a company that has such deep business and community roots spanning over a century. Together, I believe we will position Limoneira for another 100 years of sustainable growth, while still honoring its legacy and expanding on the Company's history of sustainable farming and business practices."

    About Limoneira Company

    Limoneira Company, a 128-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira (lç moñ âra) is a dedicated sustainability company with 15,400 acres of rich agricultural lands, real estate properties, and water rights in California, Arizona, Chile and Argentina. The Company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more about Limoneira Company, visit www.limoneira.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005021/en/

    Get the next $INGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INGN
    $LMNR
    $MKSI

    CompanyDatePrice TargetRatingAnalyst
    Limoneira Co
    $LMNR
    12/31/2025$19.00Buy
    Lake Street
    Limoneira Co
    $LMNR
    9/12/2025$18.00Equal-Weight
    Stephens
    MKS Inc.
    $MKSI
    7/10/2025$90.00Sell
    Goldman
    Inogen Inc
    $INGN
    6/16/2025$14.00Buy
    B. Riley Securities
    Limoneira Co
    $LMNR
    6/10/2025$23.00Hold → Buy
    Lake Street
    Inogen Inc
    $INGN
    5/22/2025$12.00Hold → Buy
    Needham
    MKS Inc.
    $MKSI
    5/20/2025$110.00Hold → Buy
    Deutsche Bank
    MKS Inc.
    $MKSI
    1/6/2025$130.00Neutral → Buy
    Citigroup
    More analyst ratings

    $INGN
    $LMNR
    $MKSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Slater Scott S bought $64,250 worth of shares (5,000 units at $12.85), increasing direct ownership by 8% to 64,447 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/9/26 4:01:10 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Director Nolan Peter J bought $254,772 worth of shares (20,000 units at $12.74), increasing direct ownership by 2% to 1,133,862 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/6/26 4:01:15 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    EVP, CFO & Treasurer Bourque Michael J. was granted 48,225 shares, converted options into 25,000 shares, covered exercise/tax liability with 28,579 shares and bought $24,960 worth of shares (3,000 units at $8.32) (SEC Form 4)

    4 - Inogen Inc (0001294133) (Issuer)

    3/4/25 6:42:36 PM ET
    $INGN
    Industrial Specialties
    Health Care

    $INGN
    $LMNR
    $MKSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Limoneira with a new price target

    Lake Street resumed coverage of Limoneira with a rating of Buy and set a new price target of $19.00

    12/31/25 8:00:29 AM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Stephens resumed coverage on Limoneira with a new price target

    Stephens resumed coverage of Limoneira with a rating of Equal-Weight and set a new price target of $18.00

    9/12/25 7:51:52 AM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Goldman initiated coverage on MKS Inc. with a new price target

    Goldman initiated coverage of MKS Inc. with a rating of Sell and set a new price target of $90.00

    7/10/25 8:57:27 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Slater Scott S bought $64,250 worth of shares (5,000 units at $12.85), increasing direct ownership by 8% to 64,447 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/9/26 4:01:10 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Director Nolan Peter J bought $254,772 worth of shares (20,000 units at $12.74), increasing direct ownership by 2% to 1,133,862 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/6/26 4:01:15 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    EVP, CFO and Treasurer Palamountain Mark covered exercise/tax liability with 3,745 shares, decreasing direct ownership by 3% to 107,206 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    12/29/25 4:00:43 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $INGN
    $LMNR
    $MKSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MKS Inc. Unveils Photonics Solutions to Advance AI, Quantum, and Biotech at Photonics West 2026

    ANDOVER, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, will showcase its latest advances at Photonics West 2026 in San Francisco, CA from January 20 to 22. MKS is helping to shape the most transformative trends supported by photonics technologies, from Artificial Intelligence (AI) to quantum, biophotonics, and security applications, and will feature cutting-edge solutions from its market-leading brands – Newport™, Ophir®, and Spectra-Physics®. "Our mission is to empower customers with precision technologies that accelerate progress across industries and science," said John Williams, Executive Vice Pres

    1/12/26 4:30:00 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

    Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the quarter and year ended December 31, 2025. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2025 to be approximately $82 million, representing year-over-year growth of approximately 2%. Full year 2025 total preliminary, unaudited revenue is expected to be approximately $349 million, representing year-over-year growth of approximately 4%. For the full year 2025, the Com

    1/12/26 8:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

    Expansion Aligns with Innovation and Growth Strategy Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of Aurora CPAP masks, a new product within the expanding Inogen portfolio. Aurora's introduction marks a significant milestone in Inogen's strategy to expand its respiratory care portfolio and now bring quality, high-performing masks to patients indicated for obstructive sleep apnea (OSA). Strategic Positioning and Market Opportunity Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen's presence in the growing sleep-therapy market and e

    1/7/26 8:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    $INGN
    $LMNR
    $MKSI
    SEC Filings

    View All

    Inogen Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Inogen Inc (0001294133) (Filer)

    1/12/26 8:41:22 AM ET
    $INGN
    Industrial Specialties
    Health Care

    SEC Form 10-K filed by Limoneira Co

    10-K - Limoneira CO (0001342423) (Filer)

    12/23/25 4:04:38 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Limoneira Co filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Limoneira CO (0001342423) (Filer)

    12/23/25 4:02:58 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $INGN
    $LMNR
    $MKSI
    Leadership Updates

    Live Leadership Updates

    View All

    Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

    Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga Rameswamy as Chief Technology Officer, effective September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, where he served as the Vice President and Global Head of Digital Health Platforms. "Naga's deep background in digital health and connected device innovation makes him an ideal fit for Inogen as we continue to expand our technology leadership," said Kevin Smith, President and Chief Executive Officer of Inogen, "His ability to integrate software, data, and devices to improve user experiences will be instrume

    9/25/25 4:05:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen's Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025. "We are thrilled to welcome Mira Sahney to the Inogen Board. Mira brings considerable management, technical, and operational experience in the medical device field to Inogen," said Elizabeth Mora, Chairperson of the Board. "Mira's appointment will further strengthen Inogen's Board with a

    2/3/25 4:00:00 PM ET
    $INGN
    $MDT
    $MYO
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

    MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of MK Raheja, Ph.D. as its Executive Vice President, Research and Development, and Brenton Taylor as its Executive Vice President, Operations, effective November 4, 2024. Sight Sciences also announced that Sam Park, its Chief Operating Officer, who oversaw both R&D and Operations, will be retiring from his role at the Company effective November 15, 2024, and will remain available as a con

    11/7/24 4:04:00 PM ET
    $INGN
    $SGHT
    Industrial Specialties
    Health Care
    Medical/Dental Instruments

    $INGN
    $LMNR
    $MKSI
    Financials

    Live finance-specific insights

    View All

    Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

    Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the quarter and year ended December 31, 2025. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2025 to be approximately $82 million, representing year-over-year growth of approximately 2%. Full year 2025 total preliminary, unaudited revenue is expected to be approximately $349 million, representing year-over-year growth of approximately 4%. For the full year 2025, the Com

    1/12/26 8:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    Limoneira Company Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

    Company Achieved Avocado and Lemon Volume Guidance for Fiscal Year 2025 Strategic Investments and Transformation Costs Initiatives in Fiscal Year 2025 Position Company for Anticipated $10 Million in Savings and Enhanced Operational Efficiency in Fiscal Year 2026 Avocado Production Capacity Set to Nearly Double with 700 Acres of Non-Bearing Trees Maturing Over Next Three to Four Years Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, today reported financial results for the fiscal fourth quarter and full year ended October 31, 2025

    12/23/25 4:05:00 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Limoneira Declares Quarterly Dividend

    On December 16, 2025, the Board of Directors of Limoneira Company (NASDAQ:LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, declared a quarterly cash dividend of $0.075 per common share payable on January 16, 2026, to stockholders of record on December 30, 2025. About Limoneira Company Limoneira Company, a 132-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira (lē moñ âra) is a dedicated sustainability company with 7,000 acres of rich agricultural lands, real estate properti

    12/17/25 8:30:00 AM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $INGN
    $LMNR
    $MKSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MKS Instruments Inc.

    SC 13G/A - MKS INSTRUMENTS INC (0001049502) (Subject)

    11/14/24 1:22:34 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Inogen Inc

    SC 13G/A - Inogen Inc (0001294133) (Subject)

    11/14/24 11:12:09 AM ET
    $INGN
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Limoneira Co

    SC 13G/A - Limoneira CO (0001342423) (Subject)

    11/7/24 7:32:12 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples